Latest Articles
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - MSN
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer MSN
Published: June 2, 2026, 12:41 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - Medical Xpress
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer Medical Xpress
Published: June 1, 2026, 8 p.m.
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 - OncLive
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 OncLive
Published: May 6, 2026, 12:02 p.m.
Defining standards for endometriosis follow-up and improvement of care - Endometriosis.org
Defining standards for endometriosis follow-up and improvement of care Endometriosis.org
Published: Oct. 28, 2025, 3:38 p.m.
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature
Published: Oct. 28, 2025, 8:59 a.m.
Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study - Frontiers
Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study Frontiers
Published: Sept. 11, 2025, 11:25 a.m.
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today
Published: April 9, 2025, 3:15 p.m.
Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report - Frontiers
Follow-up of hereditary endometrial carcinoma caused by MLH3 gene mutation: a case report Frontiers
Published: April 7, 2025, 3:32 p.m.
Link copied to clipboard!